AMI technique FDA approved by end of 2024? | Binary | | | 6 months ago | |
Major US cities adopt CO2 monitoring by mid-2025? | Binary | | | 7 months ago | |
First country to adopt CO2-based air quality standards? | Categorical | | | 7 months ago | |
Will FDA grant accelerated approval for Regenxbio's RGX-202 by end of 2025? | Binary | | | 1 month ago | |
Will Sarepta Therapeutics face legal action due to the censorship incident by December 31, 2024? | Binary | | | 5 months ago | |
Will Sarepta Therapeutics stock price drop by more than 10% following the censorship incident by August 31, 2024? | Binary | | | 5 months ago | |
Additional AMI technique validation studies published by end of 2024? | Binary | | | 6 months ago | |
Number of patients receiving AMI procedure by end of 2024 | Categorical | | | 6 months ago | |
CDC to update ventilation guidelines by end of 2024? | Binary | | | 7 months ago | |
Replication study on CO2 and SARS-CoV-2 published by end of 2024? | Binary | | | 7 months ago | |
Will Sarepta Therapeutics issue a public apology for the censorship incident by December 31, 2024? | Binary | | | 5 months ago | |
Will CVS Caremark make changes to its rebate aggregator subsidiary Zinc by end of 2024? | Binary | | | 5 months ago | |
Will CVS Caremark experience a significant drop in stock price (10% or more) by August 31, 2024 due to the settlement? | Binary | | | 5 months ago | |
Number of hospitals adopting AMI technique by end of 2024 | Categorical | | | 6 months ago | |
Will Regenxbio partner with a major pharma for RGX-202 distribution by end of 2025? | Binary | | | 1 month ago | |
What will be the FDA's decision on RGX-202 by end of 2025? | Categorical | | | 1 month ago | |
What will be RGX-202's market share in DMD treatments by end of 2027? | Categorical | | | 1 month ago | |
When will RGX-202 be launched in the market? | Categorical | | | 1 month ago | |
Will Regenxbio announce additional positive results for RGX-202 by mid-2025? | Binary | | | 1 month ago | |
What will be the outcome of Sarepta Therapeutics' relationship with the Duchenne patient advocacy organization by December 31, 2024? | Categorical | | | 5 months ago | |
What changes will Sarepta Therapeutics make to its gene therapy approach by December 31, 2024? | Categorical | | | 5 months ago | |
What will be the public reaction to Sarepta Therapeutics' gene therapy following the censorship incident by December 31, 2024? | Categorical | | | 5 months ago | |
Will CVS Caremark face additional legal actions related to drug rebate practices by end of 2024? | Binary | | | 5 months ago | |
What will be the impact on CVS Caremark's financial performance in Q4 2024? | Categorical | | | 5 months ago | |
What will be the public perception of CVS Caremark by end of 2024? | Categorical | | | 5 months ago | |
What will CVS Caremark's response be to the settlement by end of 2024? | Categorical | | | 5 months ago | |
AMI technique standard practice by mid-2025? | Binary | | | 6 months ago | |
Number of countries adopting AMI technique by end of 2024 | Categorical | | | 6 months ago | |
First industry to adopt CO2 monitoring based on new research? | Categorical | | | 7 months ago | |
Journal publishing major follow-up study on CO2 and SARS-CoV-2? | Categorical | | | 7 months ago | |
